DK1485475T3
(da)
†
|
2002-03-15 |
2008-01-21 |
Cellectis |
Hybrid meganuklease og enkeltkædet maganuklease og brug deraf
|
WO2009095742A1
(en)
*
|
2008-01-31 |
2009-08-06 |
Cellectis |
New i-crei derived single-chain meganuclease and uses thereof
|
WO2004067753A2
(en)
*
|
2003-01-28 |
2004-08-12 |
Cellectis |
Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof.
|
AU2006224248B2
(en)
*
|
2005-03-15 |
2011-01-06 |
Cellectis |
I-Crei meganuclease variants with modified specificity, method of preparation and uses thereof
|
WO2009134714A2
(en)
*
|
2008-04-28 |
2009-11-05 |
Precision Biosciences, Inc. |
Fusion molecules of rationally-designed dna-binding proteins and effector domains
|
WO2007060495A1
(en)
†
|
2005-10-25 |
2007-05-31 |
Cellectis |
I-crei homing endonuclease variants having novel cleavage specificity and use thereof
|
JP5551432B2
(ja)
*
|
2006-05-25 |
2014-07-16 |
サンガモ バイオサイエンシーズ, インコーポレイテッド |
遺伝子不活性化のための方法と組成物
|
WO2008093152A1
(en)
*
|
2007-02-01 |
2008-08-07 |
Cellectis |
Obligate heterodimer meganucleases and uses thereof
|
WO2008102198A1
(en)
*
|
2007-02-19 |
2008-08-28 |
Cellectis |
Laglidadg homing endonuclease variants having novel substrate specificity and use thereof
|
CA2689345C
(en)
|
2007-06-05 |
2017-07-11 |
Bayer Bioscience N.V. |
Methods and means for exact replacement of target dna in eukaryotic organisms
|
MX2009013663A
(es)
*
|
2007-06-22 |
2010-01-27 |
Scidose Llc |
Formulacion solubilizada de docetaxel sin tween 80.
|
EP2167666A2
(de)
|
2007-06-29 |
2010-03-31 |
Pioneer Hi-Bred International Inc. |
Verfahren zur veränderung des genoms einer monokotyledonen-zelle
|
WO2009013559A1
(en)
*
|
2007-07-23 |
2009-01-29 |
Cellectis |
Meganuclease variants cleaving a dna target sequence from the human hemoglobin beta gene and uses thereof
|
WO2009019528A1
(en)
*
|
2007-08-03 |
2009-02-12 |
Cellectis |
Meganuclease variants cleaving a dna target sequence from the human interleukin-2 receptor gamma chain gene and uses thereof
|
KR101657504B1
(ko)
*
|
2007-09-27 |
2016-09-19 |
상가모 바이오사이언스 인코포레이티드 |
생물학적으로 활성인 뉴클레아제의 신속한 생체내 확인
|
US11235026B2
(en)
|
2007-09-27 |
2022-02-01 |
Sangamo Therapeutics, Inc. |
Methods and compositions for modulating PD1
|
US8563314B2
(en)
|
2007-09-27 |
2013-10-22 |
Sangamo Biosciences, Inc. |
Methods and compositions for modulating PD1
|
CA2704383A1
(en)
|
2007-10-31 |
2009-05-07 |
James Jefferson Smith |
Rationally-designed single-chain meganucleases with non-palindromic recognition sequences
|
US20110041194A1
(en)
*
|
2007-11-28 |
2011-02-17 |
Cellectis |
I-msoi homing endonuclease variants having novel substrate specificity and use thereof
|
WO2009076292A2
(en)
*
|
2007-12-07 |
2009-06-18 |
Precision Biosciences, Inc. |
Rationally-designed meganucleases with recognition sequences found in dnase hypersensitive regions of the human genome
|
US8450561B2
(en)
|
2008-02-29 |
2013-05-28 |
Monsanto Technology Llc |
Corn plant event MON87460 and compositions and methods for detection thereof
|
WO2009114321A2
(en)
|
2008-03-11 |
2009-09-17 |
Precision Biosciencs, Inc. |
Rationally-designed meganucleases for maize genome engineering
|
US20100071083A1
(en)
*
|
2008-03-12 |
2010-03-18 |
Smith James J |
Temperature-dependent meganuclease activity
|
AU2009238629C1
(en)
|
2008-04-14 |
2015-04-30 |
Sangamo Therapeutics, Inc. |
Linear donor constructs for targeted integration
|
EP4001408A3
(de)
|
2008-07-14 |
2022-06-08 |
Precision Biosciences, Inc. |
Erkennungssequenzen für meganukleasen aus i-crei und ihre verwendung
|
JP5908725B2
(ja)
|
2008-08-22 |
2016-04-26 |
サンガモ バイオサイエンシーズ, インコーポレイテッド |
標的一本鎖開裂および標的組込みのための方法、並びに組成物
|
HUE037911T2
(hu)
*
|
2008-12-17 |
2018-09-28 |
Dow Agrosciences Llc |
Célzott integrálás a ZP15 lókuszba
|
US8551945B2
(en)
|
2009-02-04 |
2013-10-08 |
Sangamo Biosciences, Inc. |
Methods and compositions for treating neuropathies
|
US20110294217A1
(en)
*
|
2009-02-12 |
2011-12-01 |
Fred Hutchinson Cancer Research Center |
Dna nicking enzyme from a homing endonuclease that stimulates site-specific gene conversion
|
US8871905B2
(en)
|
2009-03-20 |
2014-10-28 |
Sangamo Biosciences, Inc. |
Modification of CXCR4 using engineered zinc finger proteins
|
WO2010122367A2
(en)
*
|
2009-04-21 |
2010-10-28 |
Cellectis |
Meganuclease variants cleaving the genomic insertion of a virus and uses thereof
|
US8772008B2
(en)
|
2009-05-18 |
2014-07-08 |
Sangamo Biosciences, Inc. |
Methods and compositions for increasing nuclease activity
|
WO2010136981A2
(en)
*
|
2009-05-26 |
2010-12-02 |
Cellectis |
Meganuclease variants cleaving the genome of a pathogenic non-integrating virus and uses thereof
|
WO2010136841A2
(en)
*
|
2009-05-26 |
2010-12-02 |
Cellectis |
Meganuclease variants cleaving the genome of a non-genomically integrating virus and uses thereof
|
WO2019106641A2
(en)
|
2017-12-03 |
2019-06-06 |
Seedx Technologies Inc. |
Systems and methods for sorting of seeds
|
JP5798116B2
(ja)
*
|
2009-06-30 |
2015-10-21 |
サンガモ バイオサイエンシーズ, インコーポレイテッド |
生物活性のあるヌクレアーゼの迅速なスクリーニングおよびヌクレアーゼ修飾細胞の単離
|
WO2011016840A2
(en)
|
2009-07-28 |
2011-02-10 |
Sangamo Biosciences, Inc. |
Methods and compositions for treating trinucleotide repeat disorders
|
ES2550202T3
(es)
*
|
2009-08-03 |
2015-11-05 |
Recombinetics, Inc. |
Métodos y composiciones para la modificación dirigida de genes
|
EP2464750A4
(de)
|
2009-08-11 |
2013-10-02 |
Sangamo Biosciences Inc |
Für gezielte modifikation homozygote organismen
|
ES2657067T3
(es)
|
2009-10-22 |
2018-03-01 |
Dow Agrosciences Llc |
Proteínas con dedos de zinc modificadas genéticamente que se dirigen a genes vegetales implicados en la biosíntesis de ácidos grasos
|
EP2319872A1
(de)
|
2009-11-04 |
2011-05-11 |
BASF Plant Science GmbH |
Amylopektinähnliche Stärke mit verbesserter Retrogradationsstabilität
|
CN102762726A
(zh)
|
2009-11-27 |
2012-10-31 |
巴斯夫植物科学有限公司 |
嵌合内切核酸酶及其用途
|
EP2504439B1
(de)
*
|
2009-11-27 |
2016-03-02 |
BASF Plant Science Company GmbH |
Optimierte endonukleasen und ihre verwendung
|
CN105384827A
(zh)
|
2009-11-27 |
2016-03-09 |
巴斯夫植物科学有限公司 |
嵌合内切核酸酶及其用途
|
CN102939383B
(zh)
*
|
2009-12-30 |
2015-04-29 |
先锋国际良种公司 |
用于靶向多核苷酸修饰的方法和组合物
|
US20110203012A1
(en)
*
|
2010-01-21 |
2011-08-18 |
Dotson Stanton B |
Methods and compositions for use of directed recombination in plant breeding
|
CA2788850C
(en)
|
2010-02-09 |
2019-06-25 |
Sangamo Biosciences, Inc. |
Targeted genomic modification with partially single-stranded donor molecules
|
AU2011219716A1
(en)
*
|
2010-02-26 |
2012-09-27 |
Cellectis |
Use of endonucleases for inserting transgenes into safe harbor loci
|
US20130198897A1
(en)
|
2010-03-22 |
2013-08-01 |
Philip Morris Products S.A. |
Modifying enzyme activity in plants
|
US8772453B2
(en)
|
2010-05-03 |
2014-07-08 |
Sangamo Biosciences, Inc. |
Compositions for linking zinc finger modules
|
JP6208580B2
(ja)
|
2010-05-17 |
2017-10-04 |
サンガモ セラピューティクス, インコーポレイテッド |
新規のdna結合タンパク質及びその使用
|
WO2011154158A1
(en)
|
2010-06-09 |
2011-12-15 |
Bayer Bioscience N.V. |
Methods and means to modify a plant genome at a nucleotide sequence commonly used in plant genome engineering
|
CN103119169B
(zh)
*
|
2010-06-09 |
2018-11-20 |
拜尔作物科学公司 |
植物基因组改造中常用的在核苷酸序列上修饰植物基因组的方法和工具
|
CA2805442C
(en)
|
2010-07-21 |
2020-05-12 |
Sangamo Biosciences, Inc. |
Methods and compositions for modification of an hla locus
|
CA2807270A1
(en)
*
|
2010-08-02 |
2012-02-09 |
Cellectis |
Method for targeted genomic events in diatoms
|
EP2622090B1
(de)
|
2010-09-27 |
2019-06-19 |
Sangamo Therapeutics, Inc. |
Zusammensetzungen zur hemmung des eindringens von viren in zellen
|
MX2013007852A
(es)
|
2011-01-14 |
2013-09-26 |
Univ Florida |
Arboles de frutas citricas con resistencia al chancro de los citricos.
|
US10030245B2
(en)
|
2011-03-23 |
2018-07-24 |
E I Du Pont De Nemours And Company |
Methods for producing a complex transgenic trait locus
|
WO2012138901A1
(en)
*
|
2011-04-05 |
2012-10-11 |
Cellectis Sa |
Method for enhancing rare-cutting endonuclease efficiency and uses thereof
|
JP6133275B2
(ja)
|
2011-05-02 |
2017-05-24 |
ボード・オブ・リージェンツ・オブ・ザ・ユニヴァーシティ・オブ・ネブラスカBoard Of Regents Of The University Of Nebraska |
有用な特徴を有する植物および関連する方法
|
EP2535416A1
(de)
|
2011-05-24 |
2012-12-19 |
BASF Plant Science Company GmbH |
Entwicklung einer Phytophthora-resistenten Kartoffel mit verbessertem Ertrag
|
EP3683319A1
(de)
|
2011-06-01 |
2020-07-22 |
Precision Biosciences, Inc. |
Verfahren und produkte zur herstellung manipulierter säugetierzelllinien mit verstärkten transgenen
|
WO2012168124A1
(en)
|
2011-06-06 |
2012-12-13 |
Bayer Cropscience Nv |
Methods and means to modify a plant genome at a preselected site
|
WO2012168910A1
(en)
|
2011-06-10 |
2012-12-13 |
Basf Plant Science Company Gmbh |
Nuclease fusion protein and uses thereof
|
WO2013066423A2
(en)
|
2011-06-21 |
2013-05-10 |
Pioneer Hi-Bred International, Inc. |
Methods and compositions for producing male sterile plants
|
AR087167A1
(es)
|
2011-07-12 |
2014-02-26 |
Two Blades Foundation |
Genes de resistencia al tizon tardio
|
WO2013016446A2
(en)
|
2011-07-25 |
2013-01-31 |
Sangamo Biosciences, Inc. |
Methods and compositions for alteration of a cystic fibrosis transmembrane conductance regulator (cftr) gene
|
AU2013204310C1
(en)
*
|
2011-08-22 |
2015-12-10 |
BASF Agricultural Solutions Seed US LLC |
Methods and means to modify a plant genome
|
CN103981149A
(zh)
|
2011-08-22 |
2014-08-13 |
拜尔作物科学公司 |
修饰植物基因组的方法和手段
|
US9150847B2
(en)
|
2011-09-21 |
2015-10-06 |
Sangamo Biosciences, Inc. |
Methods and compositions for regulation of transgene expression
|
CA3099582A1
(en)
|
2011-10-27 |
2013-05-02 |
Sangamo Biosciences, Inc. |
Methods and compositions for modification of the hprt locus
|
EP2612918A1
(de)
|
2012-01-06 |
2013-07-10 |
BASF Plant Science Company GmbH |
In planta-Rekombination
|
WO2013109754A1
(en)
|
2012-01-17 |
2013-07-25 |
Pioneer Hi-Bred International, Inc. |
Plant transcription factors, promoters and uses thereof
|
BR112014018294B1
(pt)
|
2012-01-26 |
2022-01-11 |
Norfolk Plant Sciences, Ltd |
Método para produzir uma planta, cassete de expressão, e, célula bacteriana
|
WO2013130824A1
(en)
|
2012-02-29 |
2013-09-06 |
Sangamo Biosciences, Inc. |
Methods and compositions for treating huntington's disease
|
WO2013136274A1
(en)
|
2012-03-13 |
2013-09-19 |
University Of Guelph |
Myb55 promoter and use thereof
|
CA2865531A1
(en)
|
2012-03-13 |
2013-09-19 |
University Of Guelph |
Methods of increasing tolerance to heat stress and amino acid content of plants
|
AU2013254857B2
(en)
|
2012-04-23 |
2018-04-26 |
Bayer Cropscience Nv |
Targeted genome engineering in plants
|
KR102091298B1
(ko)
|
2012-05-02 |
2020-03-19 |
다우 아그로사이언시즈 엘엘씨 |
말산 탈수소효소의 표적화된 변형
|
BR112014027468A2
(pt)
|
2012-05-04 |
2017-06-27 |
Du Pont |
polinucleotídeo isolado ou recombinante, construção de dna recombinante, célula, planta, explante vegetal, semente transgênica, polipeptídeo isolado, composição, métodos de produção de meganuclease, de introdução de rompimento e de integração de um polinucleotídeo.
|
CN104471067B
(zh)
|
2012-05-07 |
2020-08-14 |
桑格摩生物治疗股份有限公司 |
用于核酸酶介导的转基因靶向整合的方法和组合物
|
JP6329537B2
(ja)
|
2012-07-11 |
2018-05-23 |
サンガモ セラピューティクス, インコーポレイテッド |
生物学的薬剤の送達のための方法および組成物
|
HUE051612T2
(hu)
|
2012-07-11 |
2021-03-01 |
Sangamo Therapeutics Inc |
Eljárások és készítmények lizoszomális tárolási betegségek kezelésére
|
SG10201701601WA
(en)
|
2012-08-29 |
2017-04-27 |
Sangamo Biosciences Inc |
Methods and compositions for treatment of a genetic condition
|
EP2906684B8
(de)
|
2012-10-10 |
2020-09-02 |
Sangamo Therapeutics, Inc. |
T-zell-modifizierende verbindungen und verwendungen davon
|
CN109554350B
(zh)
|
2012-11-27 |
2022-09-23 |
儿童医疗中心有限公司 |
用于胎儿血红蛋白再诱导的靶向bcl11a远端调控元件
|
RU2015128052A
(ru)
|
2012-12-13 |
2017-01-19 |
Дау Агросайенсиз Ллс |
Точный таргетинг генов в отношении конкретного локуса кукурузы
|
CA2901676C
(en)
*
|
2013-02-25 |
2023-08-22 |
Sangamo Biosciences, Inc. |
Methods and compositions for enhancing nuclease-mediated gene disruption
|
DK2971039T3
(da)
|
2013-03-14 |
2020-04-06 |
Immusoft Corp |
Fremgangsmåder til in vitro-differentiering af hukommelses-b-celler og transduktion med vsv-g-pseudotypeomdannede virusvektorer
|
EP2981614A1
(de)
|
2013-04-02 |
2016-02-10 |
Bayer CropScience NV |
Gezielte genommanipulation bei eukaryoten
|
KR102223568B1
(ko)
|
2013-04-05 |
2021-03-04 |
다우 아그로사이언시즈 엘엘씨 |
식물의 게놈 내의 외인성 서열의 통합을 위한 방법 및 조성물
|
US20160143256A1
(en)
|
2013-07-10 |
2016-05-26 |
Joseph A. MAJZOUB |
Mrap2 knockouts
|
BR112016003591A8
(pt)
|
2013-08-22 |
2018-01-30 |
Du Pont |
promotor u6 de polimerase iii de soja e métodos de uso
|
EP3039136B8
(de)
|
2013-08-28 |
2020-12-16 |
Sangamo Therapeutics, Inc. |
Zusammensetzungen zur vernetzung von dna-bindungsdomänen und -spaltungsdomänen
|
US20160251410A1
(en)
|
2013-09-03 |
2016-09-01 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Compositions and methods for expressing recombinant polypeptides
|
US10767188B2
(en)
|
2013-09-25 |
2020-09-08 |
Nutech Ventures |
Methods and compositions for obtaining useful plant traits
|
KR20150037550A
(ko)
*
|
2013-09-30 |
2015-04-08 |
주식회사 엘지화학 |
국지적으로 편광 해소 영역을 갖는 편광판 및 그 제조 방법
|
CA3194037A1
(en)
|
2013-10-17 |
2015-04-23 |
Sangamo Biosciences, Inc. |
Delivery methods and compositions for nuclease-mediated genome engineering
|
EP3057432B1
(de)
|
2013-10-17 |
2018-11-21 |
Sangamo Therapeutics, Inc. |
Verfahren und zusammensetzungen für nukleasevermitteltes genom-engineering in hämotopoietischen stammzellen
|
BR102014027442B1
(pt)
|
2013-11-04 |
2022-09-27 |
Dow Agrosciences Llc |
Molécula de ácido nucleico recombinante, uso de uma planta de milho, parte de planta de milho ou célula de planta de milho compreendendo a mesma e método para produzir uma célula vegetal transgênica compreendendo um dna de interesse
|
UY35812A
(es)
|
2013-11-04 |
2015-05-29 |
Dow Agrosciences Llc |
?loci de maíz óptimos?.
|
NZ746567A
(en)
|
2013-11-04 |
2019-09-27 |
Dow Agrosciences Llc |
Optimal soybean loci
|
JP2016537341A
(ja)
|
2013-11-11 |
2016-12-01 |
サンガモ バイオサイエンシーズ, インコーポレイテッド |
ハンチントン病を処置するための方法および組成物
|
PL3068881T3
(pl)
|
2013-11-13 |
2019-08-30 |
Children's Medical Center Corporation |
Regulacja ekspresji genów, w której pośredniczą nukleazy
|
CA3229275A1
(en)
|
2013-12-09 |
2015-06-18 |
Sangamo Biosciences, Inc. |
Methods and compositions for genome engineering
|
KR20230007559A
(ko)
|
2013-12-20 |
2023-01-12 |
프레드 허친슨 캔서 센터 |
태그된 키메라 이펙터 분자 및 그의 리셉터
|
WO2015116680A1
(en)
|
2014-01-30 |
2015-08-06 |
Two Blades Foundation |
Plants with enhanced resistance to phytophthora
|
DK3102673T3
(da)
|
2014-02-03 |
2020-07-06 |
Sangamo Therapeutics Inc |
Fremgangsmåder og sammensætninger til behandling af beta-talassæmi
|
AU2015218576B2
(en)
|
2014-02-24 |
2020-02-27 |
Sangamo Therapeutics, Inc. |
Methods and compositions for nuclease-mediated targeted integration
|
TW201538518A
(zh)
|
2014-02-28 |
2015-10-16 |
Dow Agrosciences Llc |
藉由嵌合基因調控元件所賦予之根部特異性表現
|
CA2942268A1
(en)
|
2014-03-12 |
2015-09-17 |
Precision Biosciences, Inc. |
Dystrophin gene exon deletion using engineered nucleases
|
EP3929279A1
(de)
|
2014-03-18 |
2021-12-29 |
Sangamo Therapeutics, Inc. |
Verfahren und zusammensetzungen zur regulierung der zinkfingerproteinexpression
|
GB201407852D0
(en)
|
2014-05-02 |
2014-06-18 |
Iontas Ltd |
Preparation of libraries od protein variants expressed in eukaryotic cells and use for selecting binding molecules
|
WO2015171603A1
(en)
|
2014-05-06 |
2015-11-12 |
Two Blades Foundation |
Methods for producing plants with enhanced resistance to oomycete pathogens
|
AU2015255877B2
(en)
|
2014-05-08 |
2020-03-26 |
Chdi Foundation, Inc. |
Methods and compositions for treating huntington's disease
|
DE102014209264B8
(de)
*
|
2014-05-15 |
2017-01-12 |
Olympus Winter & Ibe Gmbh |
Hochfrequenz-Chirurgiegerät
|
AU2015266776A1
(en)
*
|
2014-05-30 |
2016-12-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions and methods of delivering treatments for latent viral infections
|
WO2016007347A1
(en)
|
2014-07-11 |
2016-01-14 |
E. I. Du Pont De Nemours And Company |
Compositions and methods for producing plants resistant to glyphosate herbicide
|
US9616090B2
(en)
|
2014-07-30 |
2017-04-11 |
Sangamo Biosciences, Inc. |
Gene correction of SCID-related genes in hematopoietic stem and progenitor cells
|
PT3194570T
(pt)
|
2014-09-16 |
2021-08-06 |
Sangamo Therapeutics Inc |
Métodos e composições para manipulação e correção de genoma mediada por nuclease em células estaminais hematopoiéticas
|
US11021718B2
(en)
|
2014-10-01 |
2021-06-01 |
The General Hospital Corporation |
Methods for increasing efficiency of nuclease-induced homology-directed repair
|
US20170327834A1
(en)
|
2014-12-15 |
2017-11-16 |
Syngenta Participations Ag |
Pesticidal microrna carriers and use thereof
|
US9963710B2
(en)
|
2014-12-23 |
2018-05-08 |
Syngenta Participations Ag |
Methods and compositions for identifying and enriching for cells comprising site specific genomic modifications
|
EP3247366A4
(de)
|
2015-01-21 |
2018-10-31 |
Sangamo Therapeutics, Inc. |
Verfahren und zusammensetzungen zur identifizierung hochspezifischer nukleasen
|
EP4218771A1
(de)
|
2015-03-27 |
2023-08-02 |
Yeda Research and Development Co. Ltd |
Verfahren zur behandlung von motoneuronenerkrankungen
|
EP3277823B1
(de)
|
2015-04-03 |
2023-09-13 |
Dana-Farber Cancer Institute, Inc. |
Zusammensetzung und verfahren zur genomänderung von b-zellen
|
CN107624136A
(zh)
|
2015-04-15 |
2018-01-23 |
美国陶氏益农公司 |
用于转基因表达的植物启动子
|
MX2017012936A
(es)
|
2015-04-15 |
2018-02-01 |
Dow Agrosciences Llc |
Promotor de plantas para la expresion transgenica.
|
US11491342B2
(en)
|
2015-07-01 |
2022-11-08 |
Btl Medical Solutions A.S. |
Magnetic stimulation methods and devices for therapeutic treatments
|
WO2016176652A2
(en)
|
2015-04-29 |
2016-11-03 |
Fred Hutchinson Cancer Research Center |
Modified stem cells and uses thereof
|
DK3289076T3
(da)
|
2015-05-01 |
2022-01-17 |
Prec Biosciences Inc |
Præcis sletning af kromosomale sekvenser in vivo
|
EP3294873B2
(de)
|
2015-05-08 |
2024-09-18 |
The Children's Medical Center Corporation |
Abzielung auf funktionelle regionen des bcl11a-enhancers zur reinduktion von fetalem hämoglobin
|
CA2985458A1
(en)
|
2015-05-09 |
2016-11-17 |
Two Blades Foundation |
Late blight resistance gene from solanum americanum and methods of use
|
WO2016181393A1
(en)
|
2015-05-11 |
2016-11-17 |
Yeda Research And Development Co. Ltd. |
Citrin inhibitors for the treatment of cancer
|
EP3447075B1
(de)
|
2015-05-15 |
2023-08-09 |
The General Hospital Corporation |
Antagonistische anti-tumor-nekrosefaktorrezeptorsuperfamilienantikörper
|
US11680244B2
(en)
|
2015-05-20 |
2023-06-20 |
The Regents Of The University Of California |
Method for generating human dendritic cells for immunotherapy
|
US10662440B2
(en)
|
2015-06-19 |
2020-05-26 |
Precision Biosciences, Inc. |
Self-limiting viral vectors encoding nucleases
|
US10669528B2
(en)
|
2015-06-25 |
2020-06-02 |
Children's Medical Center Corporation |
Methods and compositions relating to hematopoietic stem cell expansion, enrichment, and maintenance
|
CA2991301A1
(en)
|
2015-07-13 |
2017-01-19 |
Sangamo Therapeutics, Inc. |
Delivery methods and compositions for nuclease-mediated genome engineering
|
WO2017024407A1
(en)
|
2015-08-11 |
2017-02-16 |
The Royal Institution For The Advancement Of Learning/Mcgill University |
Peptidic tgf-beta antagonists
|
AU2016308339A1
(en)
|
2015-08-18 |
2018-04-12 |
Baylor College Of Medicine |
Methods and compositions for altering function and structure of chromatin loops and/or domains
|
JP6775584B2
(ja)
*
|
2015-09-08 |
2020-10-28 |
プレシジョン バイオサイエンシズ,インク. |
設計されたメガヌクレアーゼを使用した網膜色素変性症の治療
|
TW201718862A
(zh)
|
2015-09-22 |
2017-06-01 |
Dow Agrosciences Llc |
用於轉殖基因表現之植物啟動子及3’utr
|
TW201718861A
(zh)
|
2015-09-22 |
2017-06-01 |
道禮責任有限公司 |
用於轉殖基因表現之植物啟動子及3’utr
|
AU2016333898B2
(en)
|
2015-10-05 |
2020-11-12 |
Precision Biosciences, Inc. |
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
|
CA3001008A1
(en)
*
|
2015-10-05 |
2017-04-13 |
Precision Biosciences, Inc. |
Engineered meganucleases with recognition sequences found in the human t cell receptor alpha constant region gene
|
WO2017062790A1
(en)
|
2015-10-09 |
2017-04-13 |
Two Blades Foundation |
Cold shock protein receptors and methods of use
|
CN108473997B
(zh)
|
2015-10-22 |
2022-04-12 |
美国陶氏益农公司 |
用于转基因表达的植物启动子
|
TW202344686A
(zh)
|
2015-10-30 |
2023-11-16 |
美國加利福尼亞大學董事會 |
從幹細胞產生t細胞之方法及使用該t細胞之免疫療法
|
WO2017078935A1
(en)
|
2015-11-04 |
2017-05-11 |
Dow Agrosciences Llc |
Plant promoter for transgene expression
|
WO2017079428A1
(en)
|
2015-11-04 |
2017-05-11 |
President And Fellows Of Harvard College |
Site specific germline modification
|
JP2018532415A
(ja)
|
2015-11-06 |
2018-11-08 |
ザ ジャクソン ラボラトリー |
大きなゲノムdnaノックインおよびその使用
|
AU2016355178B9
(en)
|
2015-11-19 |
2019-05-30 |
Massachusetts Institute Of Technology |
Lymphocyte antigen CD5-like (CD5L)-interleukin 12B (p40) heterodimers in immunity
|
US11352631B2
(en)
|
2015-12-18 |
2022-06-07 |
Sangamo Therapeutics, Inc. |
Targeted disruption of the T cell receptor
|
AU2016374253B2
(en)
|
2015-12-18 |
2021-10-21 |
Sangamo Therapeutics, Inc. |
Targeted disruption of the MHC cell receptor
|
CA3009637A1
(en)
|
2015-12-23 |
2017-06-29 |
Precision Biosciences, Inc. |
Engineered meganucleases with recognition sequences found in the human beta-2 microglobulin gene
|
EP3400068A1
(de)
|
2016-01-06 |
2018-11-14 |
Yeda Research and Development Co., Ltd. |
Zusammensetzungen und verfahren zur behandlung von bösartigen, autoimmun- und entzündungserkrankungen
|
SG10202112024PA
(en)
|
2016-01-11 |
2021-12-30 |
Univ Leland Stanford Junior |
Chimeric proteins and methods of immunotherapy
|
US9856497B2
(en)
|
2016-01-11 |
2018-01-02 |
The Board Of Trustee Of The Leland Stanford Junior University |
Chimeric proteins and methods of regulating gene expression
|
WO2017125931A1
(en)
|
2016-01-21 |
2017-07-27 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Parthenocarpic plants and methods of producing same
|
WO2017130205A1
(en)
|
2016-01-31 |
2017-08-03 |
Hadasit Medical Research Services And Development Ltd. |
Autosomal-identical pluripotent stem cell populations having non-identical sex chromosomal composition and uses thereof
|
AU2016391970B2
(en)
|
2016-02-02 |
2024-02-22 |
Sangamo Therapeutics, Inc. |
Compositions for linking DNA-binding domains and cleavage domains
|
WO2017138008A2
(en)
|
2016-02-14 |
2017-08-17 |
Yeda Research And Development Co. Ltd. |
Methods of modulating protein exocytosis and uses of same in therapy
|
CN109069870B
(zh)
|
2016-02-24 |
2022-04-29 |
洛克菲勒大学 |
基于胚胎细胞的用于亨廷顿氏病的治疗候选物筛选系统、模型及它们的应用
|
US20190216891A1
(en)
|
2016-03-06 |
2019-07-18 |
Yeda Research And Development Co., Ltd. |
Method for modulating myelination
|
US20190119642A1
(en)
|
2016-03-15 |
2019-04-25 |
Children's Medical Center Corporation |
Methods and compositions relating to hematopoietic stem cell expansion
|
NZ745936A
(en)
|
2016-04-27 |
2020-02-28 |
Univ Puerto Rico |
1,5-disubstituted 1,2,3-triazoles are inhibitors of rac/cdc42 gtpases
|
ES2905791T3
(es)
|
2016-05-03 |
2022-04-12 |
Prec Biosciences Inc |
Nucleasas de ingeniería útiles para el tratamiento de la hemofilia A
|
CA3021682A1
(en)
|
2016-05-25 |
2017-11-30 |
Cargill Incorporated |
Engineered nucleases to generate deletion mutants in plants
|
MX2018014496A
(es)
|
2016-05-26 |
2019-03-28 |
Nunhems Bv |
Plantas productoras de frutas sin semillas.
|
EP3472342A1
(de)
|
2016-06-19 |
2019-04-24 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Screening auf chemotherapieresistenz in menschlichen haploidzellen
|
EP3475421A1
(de)
|
2016-06-22 |
2019-05-01 |
North Carolina State University |
Verfahren zur erhöhung der stickstoffnutzungseffizienz und/oder stickstoffverwertungseffizienz bei pflanzen
|
EP3487992A4
(de)
|
2016-07-21 |
2020-03-18 |
Maxcyte, Inc. |
Verfahren und zusammensetzungen zur modifizierung von genomischer dna
|
IL247368A0
(en)
|
2016-08-18 |
2016-11-30 |
Yeda Res & Dev |
Diagnostic and therapeutic uses of exosomes
|
EP3504327B1
(de)
|
2016-08-24 |
2021-10-06 |
Sangamo Therapeutics, Inc. |
Manipulierte zielspezifische nukleasen
|
US20190225974A1
(en)
|
2016-09-23 |
2019-07-25 |
BASF Agricultural Solutions Seed US LLC |
Targeted genome optimization in plants
|
EP3516044A4
(de)
|
2016-09-23 |
2020-03-11 |
Fred Hutchinson Cancer Research Center |
Tcrs spezifisch für neben-histokompatibilitäts (h)-antigen ha-1 und verwendungen davon
|
CA3038520A1
(en)
|
2016-10-03 |
2018-04-12 |
Dow Agrosciences Llc |
Plant promoter for transgene expression
|
WO2018067264A1
(en)
|
2016-10-03 |
2018-04-12 |
Dow Agrosciences Llc |
Plant promoter for transgene expression
|
US11286291B2
(en)
|
2016-10-04 |
2022-03-29 |
Precision Biosciences, Inc. |
Co-stimulatory domains for use in genetically-modified cells
|
US10662416B2
(en)
*
|
2016-10-14 |
2020-05-26 |
Precision Biosciences, Inc. |
Engineered meganucleases specific for recognition sequences in the hepatitis B virus genome
|
WO2018073393A2
(en)
|
2016-10-19 |
2018-04-26 |
Cellectis |
Tal-effector nuclease (talen) -modified allogenic cells suitable for therapy
|
JP7042263B2
(ja)
|
2016-10-20 |
2022-03-25 |
サンガモ セラピューティクス, インコーポレイテッド |
ファブリー病の治療のための方法および組成物
|
WO2018076335A1
(en)
|
2016-10-31 |
2018-05-03 |
Institute Of Genetics And Developmental Biology, Chinese Academy Of Sciences |
Compositions and methods for enhancing abiotic stress tolerance
|
EP3532106A4
(de)
|
2016-10-31 |
2020-06-24 |
Sangamo Therapeutics, Inc. |
Genkorrektur von scid-assoziierten genen bei hämotopoietischen stammzellen und vorläuferzellen
|
MA49610A
(fr)
|
2016-12-08 |
2020-05-27 |
Univ Case Western Reserve |
Procédés et compositions pour améliorer la production de myéline fonctionnelle
|
WO2018122771A1
(en)
|
2016-12-29 |
2018-07-05 |
Ukko Inc. |
Methods for identifying and de-epitoping allergenic polypeptides
|
EP3595708A4
(de)
|
2017-03-15 |
2020-12-16 |
Fred Hutchinson Cancer Research Center |
Hochwirksame mage-a1-spezifische tcrs und deren verwendungen
|
US11963966B2
(en)
|
2017-03-31 |
2024-04-23 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for treating ovarian tumors
|
EP3610266A4
(de)
|
2017-04-12 |
2021-04-21 |
Massachusetts Eye and Ear Infirmary |
Tumorsignatur für metastasen, zusammensetzungen von substanzen und verwendung davon
|
US20210115407A1
(en)
|
2017-04-12 |
2021-04-22 |
The Broad Institute, Inc. |
Respiratory and sweat gland ionocytes
|
JP7352807B2
(ja)
|
2017-04-12 |
2023-09-29 |
マジェンタ セラピューティクス インコーポレイテッド |
アリール炭化水素受容体アンタゴニスト及びその使用
|
US11680254B2
(en)
|
2017-04-21 |
2023-06-20 |
Precision Biosciences, Inc. |
Engineered meganucleases specific for recognition sequences in the PCSK9 gene
|
WO2018195486A1
(en)
|
2017-04-21 |
2018-10-25 |
The Broad Institute, Inc. |
Targeted delivery to beta cells
|
EP3615662A1
(de)
|
2017-04-28 |
2020-03-04 |
Precision Biosciences, Inc. |
Verfahren zur verringerung der dna-induzierten zytotoxizität und zur verbesserung der genbearbeitung in primärzellen
|
CA3061612A1
(en)
|
2017-04-28 |
2018-11-01 |
Acuitas Therapeutics, Inc. |
Novel carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acids
|
RU2019139045A
(ru)
|
2017-05-03 |
2021-06-03 |
Сангамо Терапьютикс, Инк. |
Способы и композиции для модификации гена регулятора трансмембранной проводимости при кистозном фиброзе (cftr)
|
WO2018204777A2
(en)
|
2017-05-05 |
2018-11-08 |
The Broad Institute, Inc. |
Methods for identification and modification of lncrna associated with target genotypes and phenotypes
|
IL252151A0
(en)
|
2017-05-07 |
2017-07-31 |
Fainzilber Michael |
Treatment of stress disorders
|
AU2018266698A1
(en)
|
2017-05-08 |
2019-11-28 |
Precision Biosciences, Inc. |
Nucleic acid molecules encoding an engineered antigen receptor and an inhibitory nucleic acid molecule and methods of use thereof
|
US10780119B2
(en)
|
2017-05-24 |
2020-09-22 |
Effector Therapeutics Inc. |
Methods and compositions for cellular immunotherapy
|
GB201708665D0
(en)
|
2017-05-31 |
2017-07-12 |
Tropic Biosciences Uk Ltd |
Compositions and methods for increasing extractability of solids from coffee beans
|
GB201708662D0
(en)
|
2017-05-31 |
2017-07-12 |
Tropic Biosciences Uk Ltd |
Compositions and methods for increasing shelf-life of banana
|
WO2018220582A1
(en)
|
2017-05-31 |
2018-12-06 |
Tropic Biosciences UK Limited |
Methods of selecting cells comprising genome editing events
|
WO2018224861A1
(en)
|
2017-06-07 |
2018-12-13 |
International Rice Research Institute |
Increasing hybrid seed production through higher outcrossing rate in cytoplasmic male sterile gramineae plants and related materials and methods
|
US11897953B2
(en)
|
2017-06-14 |
2024-02-13 |
The Broad Institute, Inc. |
Compositions and methods targeting complement component 3 for inhibiting tumor growth
|
CA3067842A1
(en)
|
2017-06-23 |
2018-12-27 |
University Of Kentucky Research Foundation |
Method of modulating the alkaloid content of a plant or part thereof
|
EP3645054A4
(de)
|
2017-06-26 |
2021-03-31 |
The Broad Institute, Inc. |
Zusammensetzungen auf der basis von crispr/cas-adenin-deaminase, systeme und verfahren zur gezielten nukleinsäureeditierung
|
JP2020529834A
(ja)
|
2017-06-30 |
2020-10-15 |
プレシジョン バイオサイエンシズ,インク. |
T細胞受容体アルファ遺伝子の改変されたイントロンを含む遺伝子改変t細胞
|
US12049643B2
(en)
|
2017-07-14 |
2024-07-30 |
The Broad Institute, Inc. |
Methods and compositions for modulating cytotoxic lymphocyte activity
|
IL253642A0
(en)
|
2017-07-24 |
2017-09-28 |
Seger Rony |
Combined treatment for cancer
|
CA3071440C
(en)
|
2017-07-31 |
2023-09-26 |
R. J. Reynolds Tobacco Company |
Methods and compositions for viral-based gene editing in plants
|
US10430138B2
(en)
*
|
2017-08-10 |
2019-10-01 |
Canon Kabushiki Kaisha |
Communication apparatus
|
US11692166B2
(en)
|
2017-08-23 |
2023-07-04 |
Technion Research & Development Foundation Limited |
Compositions and methods for improving alcohol tolerance in yeast
|
AU2018327225A1
(en)
|
2017-09-06 |
2020-02-27 |
Fred Hutchinson Cancer Center |
Strep-tag specific chimeric receptors and uses thereof
|
WO2019051135A1
(en)
|
2017-09-06 |
2019-03-14 |
Fred Hutchinson Cancer Research Center |
METHODS FOR IMPROVING ADOPTIVE CELL THERAPY
|
EP3684929A1
(de)
|
2017-09-19 |
2020-07-29 |
Tropic Biosciences UK Limited |
Modifizierung der spezifität von nichtcodierenden rna-molekülen zum silencing der genexpression in eukaryotischen zellen
|
US20200239544A1
(en)
|
2017-10-03 |
2020-07-30 |
Precision Biosciences, Inc. |
Modified epidermal growth factor receptor peptides for use in genetically-modified cells
|
EP3692152A4
(de)
|
2017-10-04 |
2021-12-01 |
The Broad Institute, Inc. |
Verfahren und zusammensetzungen zur veränderung der funktion und struktur von chromatinschleifen und/oder -domänen
|
EP3697435A1
(de)
|
2017-10-20 |
2020-08-26 |
Fred Hutchinson Cancer Research Center |
Zusammensetzungen und verfahren zur immuntherapie gegen tigit und/oder cd112r oder mit cd226-überexpression
|
JP7412341B2
(ja)
|
2017-10-31 |
2024-01-12 |
エディジーン バイオテクノロジー インコーポレイテッド |
造血幹細胞および前駆細胞の増幅のための組成物および方法
|
AU2018358054A1
(en)
|
2017-10-31 |
2020-05-07 |
Magenta Therapeutics Inc. |
Compositions and methods for hematopoietic stem and progenitor cell transplant therapy
|
WO2019089913A1
(en)
|
2017-11-01 |
2019-05-09 |
Precision Biosciences, Inc. |
Engineered nucleases that target human and canine factor viii genes as a treatment for hemophilia a
|
SG11202004003YA
(en)
|
2017-11-09 |
2020-05-28 |
Sangamo Therapeutics Inc |
Genetic modification of cytokine inducible sh2-containing protein (cish) gene
|
US12018080B2
(en)
|
2017-11-13 |
2024-06-25 |
The Broad Institute, Inc. |
Methods and compositions for treating cancer by targeting the CLEC2D-KLRB1 pathway
|
IL255664A0
(en)
|
2017-11-14 |
2017-12-31 |
Shachar Idit |
Hematopoietic stem cells with enhanced properties
|
WO2019108619A1
(en)
|
2017-11-28 |
2019-06-06 |
Two Blades Foundation |
Methods and compositions for enhancing the disease resistance of plants
|
WO2019109047A1
(en)
|
2017-12-01 |
2019-06-06 |
Fred Hutchinson Cancer Research Center |
Binding proteins specific for 5t4 and uses thereof
|
EP3707642A1
(de)
|
2017-12-03 |
2020-09-16 |
Seedx Technologies Inc. |
Systeme und verfahren zur saatgutsortierung
|
US11504748B2
(en)
|
2017-12-03 |
2022-11-22 |
Seedx Technologies Inc. |
Systems and methods for sorting of seeds
|
MX2020005878A
(es)
|
2017-12-06 |
2020-10-07 |
Magenta Therapeutics Inc |
Pautas posológicas para la movilización de células madre y progenitoras hematopoyéticas.
|
CN111902411A
(zh)
|
2018-01-03 |
2020-11-06 |
美真达治疗公司 |
用于扩增造血干细胞和祖细胞以及治疗遗传性代谢紊乱的组合物和方法
|
US11994512B2
(en)
|
2018-01-04 |
2024-05-28 |
Massachusetts Institute Of Technology |
Single-cell genomic methods to generate ex vivo cell systems that recapitulate in vivo biology with improved fidelity
|
WO2019140278A1
(en)
|
2018-01-11 |
2019-07-18 |
Fred Hutchinson Cancer Research Center |
Immunotherapy targeting core binding factor antigens
|
CA3086620A1
(en)
|
2018-01-12 |
2019-07-18 |
Basf Se |
Gene underlying the number of spikelets per spike qtl in wheat on chromosome 7a
|
US11732271B2
(en)
|
2018-01-12 |
2023-08-22 |
The Sainsbury Laboratory |
Stem rust resistance genes and methods of use
|
WO2019155465A1
(en)
|
2018-02-08 |
2019-08-15 |
Yeda Research And Development Co. Ltd. |
Methods of identifying and using agents for treating diseases associated with intestinal barrier dysfunction
|
EP3759130A1
(de)
|
2018-02-26 |
2021-01-06 |
Fred Hutchinson Cancer Research Center |
Zusammensetzungen und verfahren zur zellulären immuntherapie
|
JP2021515576A
(ja)
|
2018-03-16 |
2021-06-24 |
イミュソフト コーポレーション |
フォリスタチンを分泌するように遺伝子操作されたb細胞ならびにフォリスタチン関連疾患、状態、障害を処置するために、ならびに筋肉の成長および強度を増強するためにこれを使用する方法
|
IT201800004253A1
(it)
|
2018-04-05 |
2019-10-05 |
|
Composizioni e metodi per il trattamento della tachicardia ventricolare polimorfa catecolaminergica dominante ereditaria.
|
MX2020010795A
(es)
|
2018-04-12 |
2021-01-08 |
Prec Biosciences Inc |
Nucleasas modificadas genéticamente optimizadas que tienen especificidad para el gen de la región constante alfa del receptor de linfocitos t humanos.
|
US11142750B2
(en)
|
2018-04-12 |
2021-10-12 |
Precision Biosciences, Inc. |
Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome
|
WO2019202099A1
(en)
|
2018-04-18 |
2019-10-24 |
B.R.A.I.N. Biotechnology Research And Information Network Ag |
Enrichment of genome-edited cells
|
EP3560330B1
(de)
|
2018-04-24 |
2022-06-15 |
KWS SAAT SE & Co. KGaA |
Pflanzen mit verbesserter verdaulichkeit und markerhaplotypen
|
US11957695B2
(en)
|
2018-04-26 |
2024-04-16 |
The Broad Institute, Inc. |
Methods and compositions targeting glucocorticoid signaling for modulating immune responses
|
US20210147831A1
(en)
|
2018-04-27 |
2021-05-20 |
The Broad Institute, Inc. |
Sequencing-based proteomics
|
GB201807192D0
(en)
|
2018-05-01 |
2018-06-13 |
Tropic Biosciences Uk Ltd |
Compositions and methods for reducing caffeine content in coffee beans
|
US20210386829A1
(en)
|
2018-05-04 |
2021-12-16 |
The Broad Institute, Inc. |
Compositions and methods for modulating cgrp signaling to regulate innate lymphoid cell inflammatory responses
|
US11690921B2
(en)
|
2018-05-18 |
2023-07-04 |
Sangamo Therapeutics, Inc. |
Delivery of target specific nucleases
|
US20210371932A1
(en)
|
2018-06-01 |
2021-12-02 |
Massachusetts Institute Of Technology |
Methods and compositions for detecting and modulating microenvironment gene signatures from the csf of metastasis patients
|
US12036240B2
(en)
|
2018-06-14 |
2024-07-16 |
The Broad Institute, Inc. |
Compositions and methods targeting complement component 3 for inhibiting tumor growth
|
EP3806619A1
(de)
|
2018-06-15 |
2021-04-21 |
Nunhems B.V. |
Kernlose wassermelonenpflanzen mit modifikationen in einem abc-transporter-gen
|
US11873322B2
(en)
|
2018-06-25 |
2024-01-16 |
Yeda Research And Development Co. Ltd. |
Systems and methods for increasing efficiency of genome editing
|
AU2019297677A1
(en)
|
2018-07-04 |
2021-02-25 |
Ukko Inc. |
Methods of de-epitoping wheat proteins and use of same for the treatment of celiac disease
|
WO2020018964A1
(en)
|
2018-07-20 |
2020-01-23 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for controlled expression of antigen-specific receptors
|
GB201812603D0
(en)
|
2018-08-02 |
2018-09-19 |
British American Tobacco Investments Ltd |
Method
|
US20210317429A1
(en)
|
2018-08-20 |
2021-10-14 |
The Broad Institute, Inc. |
Methods and compositions for optochemical control of crispr-cas9
|
US20210340201A1
(en)
|
2018-08-22 |
2021-11-04 |
Fred Hutchinson Cancer Research Center |
Immunotherapy targeting kras or her2 antigens
|
EP3844266A1
(de)
|
2018-08-28 |
2021-07-07 |
Fred Hutchinson Cancer Research Center |
Verfahren und zusammensetzungen zur adoptiven t-zelltherapie unter einbeziehung von induzierter notch-signalisierung
|
WO2020051207A2
(en)
|
2018-09-04 |
2020-03-12 |
Magenta Therapeutics Inc. |
Aryl hydrocarbon receptor antagonists and methods of use
|
KR20210070305A
(ko)
|
2018-09-18 |
2021-06-14 |
브이엔브이 뉴코 인크. |
Arc 기반 캡시드 및 이의 용도
|
KR20210060533A
(ko)
|
2018-09-18 |
2021-05-26 |
상가모 테라퓨틱스, 인코포레이티드 |
프로그램화된 세포 사멸 1 (pd1) 특이적 뉴클레아제
|
US20240165232A1
(en)
|
2018-09-24 |
2024-05-23 |
Fred Hutchinson Cancer Research Center |
Chimeric receptor proteins and uses thereof
|
WO2020077236A1
(en)
|
2018-10-12 |
2020-04-16 |
The Broad Institute, Inc. |
Method for extracting nuclei or whole cells from formalin-fixed paraffin-embedded tissues
|
US20210379057A1
(en)
|
2018-10-16 |
2021-12-09 |
Massachusetts Institute Of Technology |
Nutlin-3a for use in treating a mycobacterium tuberculosis infection
|
IL262658A
(en)
|
2018-10-28 |
2020-04-30 |
Memorial Sloan Kettering Cancer Center |
Prevention of age related clonal hematopoiesis and diseases associated therewith
|
GB201817971D0
(en)
|
2018-11-02 |
2018-12-19 |
British American Tobacco Investments Ltd |
Method
|
MX2021005308A
(es)
|
2018-11-09 |
2021-09-08 |
Fred Hutchinson Cancer Center Star |
Receptores de celulas t especificos para mesotelina y su uso en inmunoterapia.
|
GB201818715D0
(en)
|
2018-11-16 |
2019-01-02 |
British American Tobacco Investments Ltd |
Method
|
CA3124110A1
(en)
|
2018-12-17 |
2020-06-25 |
The Broad Institute, Inc. |
Crispr-associated transposase systems and methods of use thereof
|
EP3898661A1
(de)
|
2018-12-21 |
2021-10-27 |
Precision BioSciences, Inc. |
Genetische modifikation des hydroxysäure-oxidase-1-gens zur behandlung von primärer hyperoxalurie
|
CN113166776A
(zh)
|
2019-01-04 |
2021-07-23 |
嘉吉公司 |
用于在植物中产生突变的工程化核酸酶
|
US11739156B2
(en)
|
2019-01-06 |
2023-08-29 |
The Broad Institute, Inc. Massachusetts Institute of Technology |
Methods and compositions for overcoming immunosuppression
|
KR20210138569A
(ko)
|
2019-01-11 |
2021-11-19 |
아퀴타스 테라퓨틱스 인크. |
활성제의 지질 나노입자 전달을 위한 지질
|
GB201900940D0
(en)
|
2019-01-23 |
2019-03-13 |
British American Tobacco Investments Ltd |
Method
|
US11857641B2
(en)
|
2019-02-06 |
2024-01-02 |
Sangamo Therapeutics, Inc. |
Method for the treatment of mucopolysaccharidosis type I
|
US20230053540A1
(en)
|
2019-02-19 |
2023-02-23 |
Massachusetts Institute Of Technology |
Treatment of liver injury
|
KR20210130189A
(ko)
|
2019-02-20 |
2021-10-29 |
프레드 헛친슨 켄서 리서치 센터 |
Ras 신항원에 특이적인 결합 단백질 및 이의 용도
|
WO2020170240A1
(en)
|
2019-02-21 |
2020-08-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method for reduction drug-induced nephrotoxicity
|
WO2020178822A1
(en)
|
2019-03-05 |
2020-09-10 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Genome-edited birds
|
JP2022525099A
(ja)
|
2019-03-11 |
2022-05-11 |
フレッド ハッチンソン キャンサー リサーチ センター |
高アビディティwt1t細胞受容体とその使用
|
WO2020186101A1
(en)
|
2019-03-12 |
2020-09-17 |
The Broad Institute, Inc. |
Detection means, compositions and methods for modulating synovial sarcoma cells
|
US20220152115A1
(en)
|
2019-03-13 |
2022-05-19 |
The Broad Institute, Inc. |
Microglial progenitors for regeneration of functional microglia in the central nervous system and therapeutics uses thereof
|
WO2020186235A1
(en)
|
2019-03-14 |
2020-09-17 |
The Broad Institute, Inc. |
Compositions and methods for modulating cgrp signaling to regulate intestinal innate lymphoid cells
|
GB201903519D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
Introducing silencing activity to dysfunctional rna molecules and modifying their specificity against a gene of interest
|
GB201903520D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
Modifying the specificity of non-coding rna molecules for silencing genes in eukaryotic cells
|
GB201903521D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
No title
|
US20220152148A1
(en)
|
2019-03-18 |
2022-05-19 |
The Broad Institute, Inc. |
Modulation of type 2 immunity by targeting clec-2 signaling
|
US20220142948A1
(en)
|
2019-03-18 |
2022-05-12 |
The Broad Institute, Inc. |
Compositions and methods for modulating metabolic regulators of t cell pathogenicity
|
WO2020205838A1
(en)
|
2019-04-02 |
2020-10-08 |
Sangamo Therapeutics, Inc. |
Methods for the treatment of beta-thalassemia
|
CA3135799A1
(en)
|
2019-04-03 |
2020-10-08 |
Precision Biosciences, Inc. |
Genetically-modified immune cells comprising a microrna-adapted shrna (shrnamir)
|
US20220204994A1
(en)
|
2019-04-05 |
2022-06-30 |
Precision Biosciences, Inc. |
Methods of preparing populations of genetically-modified immune cells
|
CN114026228A
(zh)
|
2019-05-07 |
2022-02-08 |
精密生物科学公司 |
用于识别序列的工程化大范围核酸酶的优化
|
WO2020229533A1
(en)
|
2019-05-13 |
2020-11-19 |
KWS SAAT SE & Co. KGaA |
Drought tolerance in corn
|
US20220249701A1
(en)
|
2019-05-14 |
2022-08-11 |
The Broad Institute, Inc. |
Compositions and methods for targeting multinucleated cells
|
GB201906768D0
(en)
|
2019-05-14 |
2019-06-26 |
British American Tobacco Investments Ltd |
Method
|
AR118995A1
(es)
|
2019-05-25 |
2021-11-17 |
Kws Saat Se & Co Kgaa |
Mejorador de la inducción de haploides
|
US20220226464A1
(en)
|
2019-05-28 |
2022-07-21 |
Massachusetts Institute Of Technology |
Methods and compositions for modulating immune responses
|
US20220243178A1
(en)
|
2019-05-31 |
2022-08-04 |
The Broad Institute, Inc. |
Methods for treating metabolic disorders by targeting adcy5
|
BR112021026248A2
(pt)
|
2019-06-27 |
2022-03-03 |
Two Blades Found |
Molécula de ácido nucleico isolada que codifica uma proteína atrlp23 engenheirada, proteína atrlp23 engenheirada, cassete de expressão, vetor, célula hospedeira, planta ou célula vegetal, métodos para fazer uma proteína atrlp23 engenheirada, para fazer uma molécula de ácido nucleico que codifica uma proteína atrlp23 engenheirada e para intensificar a resistência de uma planta
|
GB201909563D0
(en)
|
2019-07-03 |
2019-08-14 |
British American Tobacco Investments Ltd |
Method
|
GB201909562D0
(en)
|
2019-07-03 |
2019-08-14 |
British American Tobacco Investments Ltd |
Method
|
EP3994268A1
(de)
|
2019-07-04 |
2022-05-11 |
Ukko Inc. |
Entepitopiertes alpha-gliadin und verwendung davon zum managemen von zöliakie und glutenempfindlichkeit
|
US20210071193A1
(en)
|
2019-07-12 |
2021-03-11 |
The Regents Of The University Of California |
Plants with enhanced resistance to bacterial pathogens
|
EP3999091A1
(de)
|
2019-07-15 |
2022-05-25 |
MedImmune Limited |
Dreiteilige systeme zur proteindimerisierung und verwendungsverfahren
|
IL268111A
(en)
|
2019-07-16 |
2021-01-31 |
Fainzilber Michael |
Methods of treating pain
|
US20220273715A1
(en)
|
2019-07-25 |
2022-09-01 |
Precision Biosciences, Inc. |
Compositions and methods for sequential stacking of nucleic acid sequences into a genomic locus
|
EP4004212A1
(de)
|
2019-07-30 |
2022-06-01 |
The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Institute) |
Verfahren zur steuerung der cannabinoid-synthese in pflanzen oder zellen und nach diesem verfahren hergestellte pflanzen und zellen
|
EP4007596A1
(de)
|
2019-08-01 |
2022-06-08 |
Sana Biotechnology, Inc. |
Dux4+-exprimierende zellen und ihre verwendungen
|
EP3772542A1
(de)
|
2019-08-07 |
2021-02-10 |
KWS SAAT SE & Co. KGaA |
Modifzierung der genetischen variation bei nutzpflanzen durch modulation des pachytän-checkpointproteins 2
|
US20220282333A1
(en)
|
2019-08-13 |
2022-09-08 |
The General Hospital Corporation |
Methods for predicting outcomes of checkpoint inhibition and treatment thereof
|
CN114555790A
(zh)
|
2019-08-20 |
2022-05-27 |
弗雷德哈钦森癌症研究中心 |
Wt-1特异性t细胞免疫疗法
|
WO2021035054A1
(en)
|
2019-08-20 |
2021-02-25 |
Precision Biosciences, Inc. |
Lymphodepletion dosing regimens for cellular immunotherapies
|
WO2021035170A1
(en)
|
2019-08-21 |
2021-02-25 |
Precision Biosciences, Inc. |
Compositions and methods for tcr reprogramming using fusion proteins
|
CA3148370A1
(en)
|
2019-08-23 |
2021-03-04 |
Sana Biotechnology, Inc. |
Cd24 expressing cells and uses thereof
|
US20220298501A1
(en)
|
2019-08-30 |
2022-09-22 |
The Broad Institute, Inc. |
Crispr-associated mu transposase systems
|
WO2021067864A1
(en)
|
2019-10-02 |
2021-04-08 |
Sangamo Therapeutics, Inc. |
Zinc finger protein transcription factors for treatment of prion disease
|
KR20220071248A
(ko)
|
2019-10-02 |
2022-05-31 |
상가모 테라퓨틱스, 인코포레이티드 |
알파-시누클레인 발현을 억제시키기 위한 아연 핑거 단백질 전사 인자
|
US11981922B2
(en)
|
2019-10-03 |
2024-05-14 |
Dana-Farber Cancer Institute, Inc. |
Methods and compositions for the modulation of cell interactions and signaling in the tumor microenvironment
|
US11793787B2
(en)
|
2019-10-07 |
2023-10-24 |
The Broad Institute, Inc. |
Methods and compositions for enhancing anti-tumor immunity by targeting steroidogenesis
|
CN114846022A
(zh)
|
2019-10-17 |
2022-08-02 |
科沃施种子欧洲股份两合公司 |
通过阻抑基因的下调增强作物的疾病抗性
|
US11844800B2
(en)
|
2019-10-30 |
2023-12-19 |
Massachusetts Institute Of Technology |
Methods and compositions for predicting and preventing relapse of acute lymphoblastic leukemia
|
US20220411479A1
(en)
|
2019-10-30 |
2022-12-29 |
Precision Biosciences, Inc. |
Cd20 chimeric antigen receptors and methods of use for immunotherapy
|
IL270306A
(en)
|
2019-10-30 |
2021-05-31 |
Yeda Res & Dev |
Prevention and treatment of pre-myeloid and myeloid malignancies
|
EP4051298A1
(de)
|
2019-11-01 |
2022-09-07 |
Magenta Therapeutics, Inc. |
Dosierschema zur mobilisierung von hämatopoetischen stammzellen und vorläuferzellen
|
IL293148A
(en)
|
2019-11-19 |
2024-07-01 |
Protalix Ltd |
Removal of constructs from transduced cells
|
CA3160096A1
(en)
|
2019-12-06 |
2021-06-10 |
Bruce J. Mccreedy Jr. |
Methods for cancer immunotherapy
|
WO2021113765A1
(en)
|
2019-12-06 |
2021-06-10 |
Precision Biosciences, Inc. |
Optimized engineered meganucleases having specificity for a recognition sequence in the hepatitis b virus genome
|
EP3835309A1
(de)
|
2019-12-13 |
2021-06-16 |
KWS SAAT SE & Co. KGaA |
Verfahren zur erhöhung der kälte- oder frosttoleranz in einer pflanze
|
IL271656A
(en)
|
2019-12-22 |
2021-06-30 |
Yeda Res & Dev |
System and methods for identifying cells that have undergone genome editing
|
WO2021152587A1
(en)
|
2020-01-30 |
2021-08-05 |
Yeda Research And Development Co. Ltd. |
Treating acute liver disease with tlr-mik inhibitors
|
WO2021158915A1
(en)
|
2020-02-06 |
2021-08-12 |
Precision Biosciences, Inc. |
Recombinant adeno-associated virus compositions and methods for producing and using the same
|
AU2021241643A1
(en)
|
2020-03-25 |
2022-11-24 |
Sana Biotechnology, Inc. |
Hypoimmunogenic neural cells for the treatment of neurological disorders and conditions
|
US20230263121A1
(en)
|
2020-03-31 |
2023-08-24 |
Elo Life Systems |
Modulation of endogenous mogroside pathway genes in watermelon and other cucurbits
|
WO2021205000A2
(en)
|
2020-04-09 |
2021-10-14 |
R.J. Reynolds Tobacco Company |
Method
|
EP4143302A1
(de)
|
2020-04-27 |
2023-03-08 |
Magenta Therapeutics, Inc. |
Verfahren und zusammensetzungen zur transduktion hämatopoetischer stamm- und vorläuferzellen in vivo
|
JP2023525513A
(ja)
|
2020-05-06 |
2023-06-16 |
セレクティス ソシエテ アノニム |
細胞ゲノムにおける外因性配列の標的化挿入のための方法
|
EP4146284A1
(de)
|
2020-05-06 |
2023-03-15 |
Cellectis S.A. |
Verfahren zur genetischen modifizierung von zellen zur freisetzung therapeutischer proteine
|
WO2021231259A1
(en)
|
2020-05-11 |
2021-11-18 |
Precision Biosciences, Inc. |
Self-limiting viral vectors encoding nucleases
|
KR20230010670A
(ko)
|
2020-05-12 |
2023-01-19 |
더 트러스티스 오브 더 유니버시티 오브 펜실베니아 |
이식유전자 발현의 drg-특이적 감소를 위한 조성물
|
CA3172171A1
(en)
|
2020-05-12 |
2021-11-18 |
Victor Bartsevich |
Treatment of retinitis pigmentosa using improved engineered meganucleases
|
WO2021236852A1
(en)
|
2020-05-20 |
2021-11-25 |
Sana Biotechnology, Inc. |
Methods and compositions for treatment of viral infections
|
EP4156913A1
(de)
|
2020-05-29 |
2023-04-05 |
KWS SAAT SE & Co. KGaA |
Pflanzliche haploidinduktion
|
AU2021308681A1
(en)
|
2020-07-16 |
2023-03-09 |
Acuitas Therapeutics, Inc. |
Cationic lipids for use in lipid nanoparticles
|
WO2022035793A1
(en)
|
2020-08-10 |
2022-02-17 |
Precision Biosciences, Inc. |
Antibodies and fragments specific for b-cell maturation antigen and uses thereof
|
JP2023537923A
(ja)
|
2020-08-13 |
2023-09-06 |
サナ バイオテクノロジー,インコーポレイテッド |
感作患者を低免疫原性細胞で処置する方法、ならびに関連する方法及び組成物
|
US20230309480A1
(en)
|
2020-08-18 |
2023-10-05 |
International Rice Research Institute |
Methods of increasing outcrossing rates in gramineae
|
EP4200412A1
(de)
|
2020-08-21 |
2023-06-28 |
Precision BioSciences, Inc. |
Manipulierte meganukleasen mit spezifität für eine erkennungssequenz im transthyretin-gen
|
WO2022046760A2
(en)
|
2020-08-25 |
2022-03-03 |
Kite Pharma, Inc. |
T cells with improved functionality
|
CN116724053A
(zh)
|
2020-09-24 |
2023-09-08 |
弗雷德哈钦森癌症中心 |
靶向sox2抗原的免疫治疗
|
WO2022066973A1
(en)
|
2020-09-24 |
2022-03-31 |
Fred Hutchinson Cancer Research Center |
Immunotherapy targeting pbk or oip5 antigens
|
IL301393A
(en)
|
2020-09-25 |
2023-05-01 |
Sangamo Therapeutics Inc |
Zinc finger proteins are fused to edit nuclear bases
|
KR20230113283A
(ko)
|
2020-10-05 |
2023-07-28 |
프로탈릭스 리미티드 |
다이서-유사 넉아웃 식물 세포
|
WO2022076353A1
(en)
|
2020-10-06 |
2022-04-14 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for treating mage-a1-expressing disease
|
WO2022076547A1
(en)
|
2020-10-07 |
2022-04-14 |
Precision Biosciences, Inc. |
Lipid nanoparticle compositions
|
EP4228637A1
(de)
|
2020-10-15 |
2023-08-23 |
Yeda Research and Development Co. Ltd |
Verfahren zur behandlung von myeloidmalignitäten
|
MX2023004761A
(es)
|
2020-10-23 |
2023-07-17 |
Elo Life Systems Inc |
Metodos para producir plantas de vainilla con mejor sabor y produccion agronomica.
|
TW202233844A
(zh)
|
2020-10-29 |
2022-09-01 |
賓州大學委員會 |
Aav衣殼及含有其之組成物
|
CA3172481A1
(en)
|
2020-11-12 |
2022-05-19 |
Precision Biosciences, Inc. |
Engineered meganucleases having specificity for recognition sequences in the dystrophin gene
|
WO2022115498A1
(en)
|
2020-11-26 |
2022-06-02 |
Ukko Inc. |
Modified high molecular weight glutenin subunit and uses thereof
|
WO2022132836A2
(en)
|
2020-12-14 |
2022-06-23 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for cellular immunotherapy
|
IL279559A
(en)
|
2020-12-17 |
2022-07-01 |
Yeda Res & Dev |
Controlling the ubiquitination process of mlkl for disease treatment
|
KR20230137900A
(ko)
|
2020-12-31 |
2023-10-05 |
사나 바이오테크놀로지, 인크. |
Car-t 활성을 조정하기 위한 방법 및 조성물
|
WO2022150616A1
(en)
|
2021-01-08 |
2022-07-14 |
Precision Biosciences, Inc. |
Engineered meganucleases having specificity for a recognition sequence in the hydroxyacid oxidase 1 gene
|
WO2022165111A1
(en)
|
2021-01-28 |
2022-08-04 |
Precision Biosciences, Inc. |
Modulation of tgf beta signaling in genetically-modified eukaryotic cells
|
EP4308694A1
(de)
|
2021-03-16 |
2024-01-24 |
Magenta Therapeutics, Inc. |
Dosierschemata zur mobilisierung hämatopoetischer stammzellen für stammzelltransplantationen bei patienten mit multiplem myelom
|
EP4326861A1
(de)
|
2021-04-22 |
2024-02-28 |
Precision Biosciences, Inc. |
Manipulierte meganukleasen gegen menschliche mitochondriale genome
|
WO2022226303A1
(en)
|
2021-04-22 |
2022-10-27 |
Precision Biosciences, Inc. |
Engineered meganucleases that target human mitochondrial genomes
|
WO2022226316A1
(en)
|
2021-04-22 |
2022-10-27 |
Precision Biosciences, Inc. |
Compositions and methods for generating male sterile plants
|
WO2022232267A1
(en)
|
2021-04-27 |
2022-11-03 |
The Trustees Of The University Of Pennsylvania |
Porcine-derived adeno-associated virus capsids and uses thereof
|
CA3217972A1
(en)
|
2021-05-10 |
2022-11-17 |
Haitham AMAL |
Pharmaceutical compositions for treating neurological conditions
|
CA3219611A1
(en)
|
2021-05-11 |
2022-11-17 |
Two Blades Foundation |
Methods for preparing a library of plant disease resistance genes for functional testing for disease resistance
|
EP4342983A1
(de)
|
2021-05-18 |
2024-03-27 |
Cells & Genes Biotech (Shanghai) Co., Ltd |
Verfahren zur modifizierung von zellen
|
EP4347797A1
(de)
|
2021-05-27 |
2024-04-10 |
Sana Biotechnology, Inc. |
Hypoimmunogene zellen mit manipuliertem hla-e oder hla-g
|
CA3223344A1
(en)
|
2021-07-02 |
2023-01-05 |
Tropic Biosciences UK Limited |
Delay or prevention of browning in banana fruit
|
KR20240046319A
(ko)
|
2021-07-14 |
2024-04-08 |
사나 바이오테크놀로지, 인크. |
저면역원성 세포에서의 y 염색체-연결 항원의 변경된 발현
|
TW202317602A
(zh)
|
2021-07-15 |
2023-05-01 |
福瑞德哈金森腫瘤中心 |
嵌合多肽
|
EP4376596A1
(de)
|
2021-07-30 |
2024-06-05 |
KWS SAAT SE & Co. KGaA |
Pflanzen mit verbesserter verdaulichkeit und markerhaplotypen
|
AU2022324040A1
(en)
|
2021-08-04 |
2024-02-22 |
The Regents Of The University Of Colorado, A Body Corporate |
Lat activating chimeric antigen receptor t cells and methods of use thereof
|
WO2023018621A1
(en)
|
2021-08-10 |
2023-02-16 |
Gamida-Cell Ltd. |
Engineered nk cells, methods of their production and uses thereof
|
JP2024531234A
(ja)
|
2021-08-11 |
2024-08-29 |
サナ バイオテクノロジー,インコーポレイテッド |
同種異系細胞療法のための遺伝子改変された初代細胞
|
AU2022326565A1
(en)
|
2021-08-11 |
2024-02-08 |
Sana Biotechnology, Inc. |
Genetically modified cells for allogeneic cell therapy
|
WO2023019225A2
(en)
|
2021-08-11 |
2023-02-16 |
Sana Biotechnology, Inc. |
Genetically modified cells for allogeneic cell therapy to reduce instant blood mediated inflammatory reactions
|
EP4384188A1
(de)
|
2021-08-11 |
2024-06-19 |
Sana Biotechnology, Inc. |
Induzierbare systeme zur veränderung der genexpression in hypoimmunogenen zellen
|
AU2022325231A1
(en)
|
2021-08-11 |
2024-02-08 |
Sana Biotechnology, Inc. |
Genetically modified cells for allogeneic cell therapy to reduce complement-mediated inflammatory reactions
|
GB202112866D0
(en)
|
2021-09-09 |
2021-10-27 |
Tropic Biosciences Uk Ltd |
Resistance to fusarium wilt in a banana
|
GB202112865D0
(en)
|
2021-09-09 |
2021-10-27 |
Tropic Biosciences Uk Ltd |
Resistance to black sigatoka disease in banana
|
EP4408859A1
(de)
|
2021-09-30 |
2024-08-07 |
Two Blades Foundation |
Pflanzenkrankheitsresistenzgene gegen stammrost und verfahren zur verwendung
|
WO2023064872A1
(en)
|
2021-10-14 |
2023-04-20 |
Precision Biosciences, Inc. |
Combinations of anti-bcma car t cells and gamma secretase inhibitors
|
AU2022371430A1
(en)
|
2021-10-19 |
2024-05-30 |
Precision Biosciences, Inc. |
Gene editing methods for treating alpha-1 antitrypsin (aat) deficiency
|
EP4419660A2
(de)
|
2021-10-19 |
2024-08-28 |
Precision BioSciences, Inc. |
Geneditierungsverfahren zur behandlung von alpha-1-antitrypsin (aat)-mangel
|
EP4419117A1
(de)
|
2021-10-22 |
2024-08-28 |
Sana Biotechnology, Inc. |
Verfahren zur züchtung allogener t-zellen mit einem transgen in einem tcr-lokus sowie zugehörige zusammensetzungen und verfahren
|
EP4426832A1
(de)
|
2021-11-03 |
2024-09-11 |
The J. David Gladstone Institutes, A Testamentary Trust Established under The Will of J. David Gladstone |
Genaue genomeditierung mit retrons
|
WO2023081767A1
(en)
|
2021-11-05 |
2023-05-11 |
Precision Biosciences, Inc. |
Methods for immunotherapy
|
WO2023086847A1
(en)
|
2021-11-10 |
2023-05-19 |
Encodia, Inc. |
Methods for barcoding macromolecules in individual cells
|
WO2023087019A2
(en)
|
2021-11-15 |
2023-05-19 |
The Trustees Of The University Of Pennsylvania |
Compositions for drg-specific reduction of transgene expression
|
WO2023091910A1
(en)
|
2021-11-16 |
2023-05-25 |
Precision Biosciences, Inc. |
Methods for cancer immunotherapy
|
WO2023093862A1
(en)
|
2021-11-26 |
2023-06-01 |
Epigenic Therapeutics Inc. |
Method of modulating pcsk9 and uses thereof
|
AU2022402249A1
(en)
|
2021-12-03 |
2024-07-11 |
President And Fellows Of Harvard College |
Compositions and methods for efficient in vivo delivery
|
IL313518A
(en)
|
2021-12-17 |
2024-08-01 |
Tropic Biosciences Uk Ltd |
Agrobacteria adapted for gene editing in plants
|
CN118591626A
(zh)
|
2021-12-22 |
2024-09-03 |
桑格摩生物治疗股份有限公司 |
用于核碱基编辑的新型锌指融合蛋白
|
WO2023122337A1
(en)
|
2021-12-23 |
2023-06-29 |
Sana Biotechnology, Inc. |
Chimeric antigen receptor (car) t cells for treating autoimmune disease and associated methods
|
AU2023205923A1
(en)
|
2022-01-07 |
2024-08-15 |
Precision Biosciences, Inc. |
Optimized polynucleotides for protein expression
|
WO2023141602A2
(en)
|
2022-01-21 |
2023-07-27 |
Renagade Therapeutics Management Inc. |
Engineered retrons and methods of use
|
WO2023148476A1
(en)
|
2022-02-03 |
2023-08-10 |
Nicoventures Trading Limited |
Method of modulating alkaloid content in tobacco plants
|
WO2023148478A1
(en)
|
2022-02-03 |
2023-08-10 |
Nicoventures Trading Limited |
Method of modulating alkaloid content in tobacco plants
|
AU2023215671A1
(en)
|
2022-02-04 |
2024-08-15 |
Nicoventures Trading Limited |
Method of modulating alkaloid content in tobacco plants
|
WO2023154578A1
(en)
|
2022-02-14 |
2023-08-17 |
Sana Biotechnology, Inc. |
Methods of treating patients exhibiting a prior failed therapy with hypoimmunogenic cells
|
WO2023158836A1
(en)
|
2022-02-17 |
2023-08-24 |
Sana Biotechnology, Inc. |
Engineered cd47 proteins and uses thereof
|
WO2023161178A1
(en)
|
2022-02-22 |
2023-08-31 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Cgas super-enzymes for cancer immunotherapy
|
WO2023173123A1
(en)
|
2022-03-11 |
2023-09-14 |
Sana Biotechnology, Inc. |
Genetically modified cells and compositions and uses thereof
|
WO2023196818A1
(en)
|
2022-04-04 |
2023-10-12 |
The Regents Of The University Of California |
Genetic complementation compositions and methods
|
GB202205149D0
(en)
|
2022-04-07 |
2022-05-25 |
Nicoventures Trading Ltd |
Method
|
GB202205148D0
(en)
|
2022-04-07 |
2022-05-25 |
Nicoventures Trading Ltd |
Method
|
GB202205562D0
(en)
|
2022-04-14 |
2022-06-01 |
Nicoventures Trading Ltd |
Method
|
GB202205561D0
(en)
|
2022-04-14 |
2022-06-01 |
Nicoventures Trading Ltd |
Method
|
GB202206107D0
(en)
|
2022-04-27 |
2022-06-08 |
Nicoventures Trading Ltd |
Method
|
GB202206109D0
(en)
|
2022-04-27 |
2022-06-08 |
Nicoventures Trading Ltd |
Method
|
WO2023215725A1
(en)
|
2022-05-02 |
2023-11-09 |
Fred Hutchinson Cancer Center |
Compositions and methods for cellular immunotherapy
|
WO2023215498A2
(en)
|
2022-05-05 |
2023-11-09 |
Modernatx, Inc. |
Compositions and methods for cd28 antagonism
|
WO2023220035A1
(en)
|
2022-05-09 |
2023-11-16 |
Synteny Therapeutics, Inc. |
Erythroparvovirus compositions and methods for gene therapy
|
WO2023220040A1
(en)
|
2022-05-09 |
2023-11-16 |
Synteny Therapeutics, Inc. |
Erythroparvovirus with a modified capsid for gene therapy
|
WO2023220043A1
(en)
|
2022-05-09 |
2023-11-16 |
Synteny Therapeutics, Inc. |
Erythroparvovirus with a modified genome for gene therapy
|
EP4278891A1
(de)
|
2022-05-20 |
2023-11-22 |
KWS SAAT SE & Co. KGaA |
Kohlhernienresistenz und marker in brassica
|
WO2024015966A2
(en)
|
2022-07-15 |
2024-01-18 |
The Trustees Of The University Of Pennsylvania |
Recombinant aav having aav clade d and clade e capsids and compositions containing same
|
WO2024040222A1
(en)
|
2022-08-19 |
2024-02-22 |
Generation Bio Co. |
Cleavable closed-ended dna (cedna) and methods of use thereof
|
WO2024044723A1
(en)
|
2022-08-25 |
2024-02-29 |
Renagade Therapeutics Management Inc. |
Engineered retrons and methods of use
|
WO2024042199A1
(en)
|
2022-08-26 |
2024-02-29 |
KWS SAAT SE & Co. KGaA |
Use of paired genes in hybrid breeding
|
WO2024056902A2
(en)
|
2022-09-16 |
2024-03-21 |
Christopher Shaw |
Compositions and methods for treating neurological diseases
|
WO2024079157A1
(en)
|
2022-10-11 |
2024-04-18 |
KWS SAAT SE & Co. KGaA |
Virus and insect resistance and markers in barley
|
WO2024097639A1
(en)
|
2022-10-31 |
2024-05-10 |
Modernatx, Inc. |
Hsa-binding antibodies and binding proteins and uses thereof
|
WO2024102277A2
(en)
|
2022-11-07 |
2024-05-16 |
Syngenta Crop Protection Ag |
Genes altering soy plant flowering time and/or maturation and uses thereof
|
WO2024118866A1
(en)
|
2022-12-01 |
2024-06-06 |
Modernatx, Inc. |
Gpc3-specific antibodies, binding domains, and related proteins and uses thereof
|
WO2024124044A1
(en)
|
2022-12-07 |
2024-06-13 |
The Brigham And Women’S Hospital, Inc. |
Compositions and methods targeting sat1 for enhancing anti¬ tumor immunity during tumor progression
|
WO2024126696A1
(en)
|
2022-12-14 |
2024-06-20 |
King's College London |
Compositions and methods for treating neurological diseases
|
WO2024148167A1
(en)
|
2023-01-05 |
2024-07-11 |
Precision Biosciences, Inc. |
Optimized engineered meganucleases having specificity for the human t cell receptor alpha constant region gene
|
WO2024151541A1
(en)
|
2023-01-09 |
2024-07-18 |
Sana Biotechnology, Inc. |
Type-1 diabetes autoimmune mouse
|
GB202300905D0
(en)
|
2023-01-20 |
2023-03-08 |
Nicoventures Trading Ltd |
Method
|
WO2024161022A2
(en)
|
2023-02-03 |
2024-08-08 |
King's College London |
Compositions and methods for treating neurological diseases
|
WO2024167814A1
(en)
|
2023-02-06 |
2024-08-15 |
Bluerock Therapeutics Lp |
Degron fusion proteins and methods of production and use thereof
|
GB202303077D0
(en)
|
2023-03-02 |
2023-04-19 |
Univ Oslo |
Brassica plants with improved seed retention
|
GB202305021D0
(en)
|
2023-04-04 |
2023-05-17 |
Tropic Biosciences Uk Ltd |
Methods for generating breaks in a genome
|